Pancreatic Cancer: Know the Risk Factors and Warning Signs Before It Is Too Late

Roughly 670 people are diagnosed each year in Ireland, and most cases are found at an advanced stage with a five-year survival of 13%.
The disease is quiet, and it is usually found late.
Fusai explains why only 13% of Irish patients survive five years after a pancreatic cancer diagnosis.
Mark

Why does a cancer that affects only about 670 people a year in Ireland get this much attention?

Mimi

Because of the outcome. Only 13% of patients live five years or more, and that is largely because it is found late.

Mark

Why is it found late?

Mimi

The surgeon calls it quiet. Early signs like vague abdominal pain, backache and weight loss look like a dozen other things.

Luke

So nobody should read those symptoms as a cancer warning on their own. The advice is to investigate anything that doesn't resolve quickly.

Mark

Are there signs that are more specific?

Mimi

Two. Newly diagnosed diabetes, which he says should prompt an urgent scan, and jaundice, meaning yellow skin or eyes and dark urine, from a blocked bile duct.

Luke

Worth noting those are one surgeon's clinical guidance in this piece, not a screening programme. Nothing here says everyone with new diabetes will have cancer.

Mark

What about treatment?

Mimi

Surgery is the main hope, but only about 15% of newly diagnosed patients are operable. For tumours in the head of the pancreas it is the Whipple procedure.

Luke

And the article doesn't say what survival looks like for those 15%. That figure is still unknown from this reporting.

Mark

What is the takeaway?

Mimi

Know the risk factors, such as smoking, alcohol, obesity, diabetes and family history, and don't sit on symptoms that linger.

  • Roughly 670 Irish families each year receive a diagnosis that arrives too late for most of them to be operated on.
  • Vague abdominal pain, backache and weight loss hide in ordinary life, so the first warning is often dismissed.
  • New diabetes and yellowing skin or eyes are sounding alarms that demand a scan without delay.
  • Only about 15 percent of patients can be operated on, so the race is to investigate early enough to change the outcome.
  • Doctors are navigating scans, biopsies and, where surgery is closed off, chemotherapy or radiotherapy to buy time.

Each year around 670 people in Ireland learn that they have pancreatic cancer, a disease far less common than breast cancer yet among the most unforgiving. Its danger lies in its quietness: a gland tucked behind the stomach can harbour a growing malignancy while the body offers only vague, easily excused signals. The reasons it arrives so late are as much about the body's silence as about the disease itself, and the hard arithmetic of survival, with only about 13 percent of patients still living five years on, reflects how rarely the cancer is caught while it can still be cut away.

Each year in Ireland, around 670 people are told they have pancreatic cancer. It is rarer than breast cancer, but among the deadliest, and only 13 percent of those diagnosed are alive five years later.

The surgeon Fusai, whose comments anchor this account, names the core problem: the disease is quiet. The pancreas sits at the back of the stomach, and by the time a tumour makes itself known it has often spread. Most cancers there are exocrine, and the great majority are ductal adenocarcinomas.

Some risks are known. Age, being male, family history and certain inherited gene changes such as BRCA2 raise the odds. Smoking is, in Fusai's view, among the most important factors, while heavy drinking, obesity and diabetes also contribute.

The symptoms are the difficulty. Vague pain, backache and weight loss can mean many things, so they are easily ignored. Fusai's advice is blunt: anything that does not clear quickly should be checked. New-onset diabetes should prompt urgent investigation and a scan, and jaundice, with dark urine, points to a blocked bile duct.

Diagnosis usually begins with a contrast-enhanced CT scan, with biopsy, liver MRI or PET used as needed. Surgery, including the demanding Whipple procedure for tumours in the head of the pancreas, is possible for only about 15 percent of patients. For the rest, chemotherapy or radiotherapy aims to control the disease and extend life.

The practical message is about timing. Because so few cases can be operated on at diagnosis, getting persistent or unusual symptoms checked early remains the most important lever available.

Each year in Ireland, around 670 people are told they have pancreatic cancer. It is not one of the common cancers, far rarer than breast cancer, but it is among the deadliest. Only 13% of patients are alive five years or more after diagnosis.

The surgeon Fusai, whose comments form the basis of this account, puts the main problem plainly: the disease is quiet. It tends to be found late, often after it has already spread to other organs. The pancreas is a gland that sits at the back of the stomach, and cancer there begins when abnormal cells grow and divide without control.

About 95% of pancreatic cancers are exocrine cancers. The great majority of patients have pancreatic ductal adenocarcinoma. A smaller number have rarer variants, among them acinar cell carcinoma and adenosquamous carcinoma.

Several risk factors are known. The disease is more common in older people and slightly more common in men than in women. Family history matters: the risk rises for people with a first-degree relative who has had pancreatic cancer, or who carry certain inherited gene changes such as BRCA2. Fusai calls smoking one of the biggest and most important risk factors. Heavy drinking can inflame the pancreas and lead to chronic pancreatitis, and people with that condition are more likely to develop the cancer. Obesity, being overweight and diabetes are also named as risk factors.

The early symptoms are the difficulty. Vague abdominal pain, backache and weight loss can all point to many other things, which is why they are easy to dismiss. Fusai advises against ignoring them and says any symptom that does not clear up quickly should be investigated.

He highlights two more specific warnings. New-onset diabetes can be an early sign, and in his words a new diabetes diagnosis should always prompt urgent investigation and a scan. Jaundice is the other red flag: yellowing of the skin and the whites of the eyes, together with dark urine, suggests a blocked bile duct. That duct carries bile from the liver into the intestine, and a growth in the pancreas can obstruct it.

The gold standard test is a contrast-enhanced CT scan, which clearly shows a mass in the pancreas. If more confirmation is needed, a biopsy may be done. A liver MRI or an FDG PET scan may also be used.

Treatment depends on the size and type of the cancer, its location, whether it has spread, and the patient's general health. Surgery is possible when the cancer is found early and has not spread, but that applies to only about 15% of newly diagnosed patients. For them, doctors often recommend a radical resection. A tumour in the head of the pancreas calls for a Whipple procedure, which Fusai describes as extensive and complex. When surgery is not an option, chemotherapy or radiotherapy may be offered to control the cancer and help patients live longer.

The practical message is about timing: because so few cases are operable at diagnosis, getting persistent or unusual symptoms checked early is the main lever available.

Newly diagnosed diabetes should always prompt urgent investigations and a scan.
— Fusai, surgeon
Smoking remains one of the biggest and most important risk factors of pancreatic cancer.
— Fusai, surgeon
Envie de l'histoire complète ? Lire l'original sur Irish Examiner ↗
Nous contacter FAQ